Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

rossari.com

Founded Year

2003

Stage

IPO | IPO

Date of IPO

7/15/2020

Market Cap

53.70B

About Rossari Biotech

Rossari Biotech manufactures textile specialty chemicals. It provides customized solutions to the apparel, animal & poultry feed, and FMCG industries by offering a diversified product portfolio.

Rossari Biotech Headquarters Location

201 A & B, Ackruti Corporate Park Next to G.E.Gardens, LBS Marg, Kanjurmarg West

Mumbai, 400 078,

India

+91-22-6123 3800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Rossari Biotech News

Rossari Biotech Q1 Review - Building Product Pipeline To Drive The Business Growth: KRChoksey

Aug 10, 2022

10:20 PM IST, 10 Aug 2022 10:20 PM IST, 10 Aug 2022 10:20 PM IST, 10 Aug 2022 Save BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. KRChoksey Research Report Rossari Biotech Ltd. consolidate revenue grew by 88% YoY at Rs 4,347 million (5% below our estimates) which includes mergers’ impact and can’t be compared directly with Q1 FY22; however, it has observed decline by 1% QoQ in revenue. Standalone revenue reported at Rs 2,337 million (up 14.6% YoY / 10.7% down QoQ). Rossari Biotech's Ebitda reported at Rs 577 million (up 52% YoY / up 10% QoQ; 5% above our estimates); as Ebitda margin reported at 13.3% (down 310 bps YoY / up 136.3 bps QoQ) on account of price increases and softening of raw material prices (above our estimates of 12.0%). Profit after tax reported at Rs 286.81 (17% YoY/ 19% QoQ) as against Rs 240.8 million in Q4 FY22. Click on the attachment to read the full report: KRChoksey Rossari Biotech Ltd Q1FY23 Result Update.pdf View Document DISCLAIMER This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime. Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Rossari Biotech Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Rossari Biotech Rank

  • When was Rossari Biotech founded?

    Rossari Biotech was founded in 2003.

  • Where is Rossari Biotech's headquarters?

    Rossari Biotech's headquarters is located at 201 A & B, Ackruti Corporate Park, Mumbai.

  • What is Rossari Biotech's latest funding round?

    Rossari Biotech's latest funding round is IPO.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.